CADTH Interim Organizational Assignments

February 23, 2010

Dr. Brian O’Rourke has relinquished his role as Vice-President of the Common Drug Review to focus entirely on his interim duties as  President and CEO.

With the recent integration of our science directorates, CADTH will continue to deliver on 2009/2010 commitments. These concurrent objectives call for proven leadership capability and resources. CADTH is pleased, therefore, to announce the following interim organizational assignments until fiscal year-end (March 31, 2010).

Barb Shea has been appointed Senior Vice-President, Science Directorates, and will oversee CADTH’s Health Technology Assessment (HTA), Common Drug Review (CDR), and Canadian Optimal Medication Prescribing and Utilization Service (COMPUS) programs. In her new position, Barb will be the primary contact for liaison with industry.

Tammy Clifford continues in her current role as Vice-President, HTA, while beginning to develop concepts and plans for the “Advancing the Science” portfolio.

Jane Farquharson has been named Acting Vice-President, Communications and Knowledge Exchange (CKE), in addition to her duties as the Director of Knowledge Exchange and the Liaison Program.

Glenna Benson remains in her current capacity as Vice-President, Corporate Services.

Denis Belanger, Director of Topics and Research, and Sandy Pagotto, Director of Programs and Reviews, are assuming senior director roles. They are responsible for day-to-day operations, and are accountable for the delivery of products and services for each group.

Bill Leslie will directly support Barb Shea’s industry liaison work in his current position as Director, Interventions and Outreach.